Micafungin and Eltrombopag olamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micafungin (micafungin sodium) and Eltrombopag olamine (eltrombopag olamine). Common drug interactions include anaemia among females and bone marrow failure among males.

The phase IV clinical study analyzes what interactions people have when they take Micafungin and Eltrombopag olamine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Micafungin?

Micafungin has active ingredients of micafungin sodium. eHealthMe is studying from 6,562 Micafungin users. Check the latest studies of Micafungin.

What is Eltrombopag olamine?

Eltrombopag olamine has active ingredients of eltrombopag olamine. eHealthMe is studying from 3,901 Eltrombopag olamine users. Check the latest studies of Eltrombopag olamine.

On Jul, 14, 2026

13 people who take Micafungin and Eltrombopag olamine together, and have interactions are studied.

Micafungin and Eltrombopag olamine drug interactions.

What are the common drug interactions of Micafungin and Eltrombopag Olamine, by gender? *:

female:

Anaemia (lack of blood)
Liver disorder (liver diseases)
Abdominal pain upper
Alanine aminotransferase increased
Aspartate aminotransferase increased
Bilirubin conjugated increased
Blood alkaline phosphatase increased
Blood bilirubin increased
Haematuria (presence of blood in urine)
Hyperbilirubinaemia (excess of bilirubin in the blood)

male:

Bone marrow failure
Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
Hepatic failure (liver failure)
Hyperlactacidaemia (the acidosis and also reduces the capacity of the kidney)
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Leukocytosis (increased white blood cells)
Platelet count decreased
Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
Septic shock (shock due to blood infection)

What are the common drug interactions of Micafungin and Eltrombopag Olamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Abdominal pain upper
Alanine aminotransferase increased
Anaemia (lack of blood)
Aspartate aminotransferase increased
Bilirubin conjugated increased
Blood alkaline phosphatase increased
Blood bilirubin increased
Haematuria (presence of blood in urine)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Hypertension (high blood pressure)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Bone marrow failure
Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
Liver abscess (pus in liver)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Pneumonia
Abdominal pain
Anuria (failure of the kidneys to produce urine)
C-reactive protein increased
Dizziness
Hepatic failure (liver failure)

60+:

Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Device related infection
Septic shock (shock due to blood infection)
Drug eruption (adverse drug reaction of the skin)
Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
Interstitial lung disease
Oxygen saturation decreased
Pericardial effusion (fluid around the heart)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Pyrexia (fever)

What are the existing conditions these people have? *

Aplastic Anemia: 4 people, 30.77%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 23.08%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 15.38%
Insomnia (sleeplessness): 2 people, 15.38%
Visual Impairment: 1 person, 7.69%
Hiv Infection: 1 person, 7.69%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 7.69%
Fungal Infection: 1 person, 7.69%
Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 7.69%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Micafungin and Eltrombopag olamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously